The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity

BACKGROUND: the mainstay of treatment of polymyalgia rheumatica (PMR) is oral glucocorticoids, but randomized controlled trials of treatment are lacking. As a result, there is no evidence from controlled studies on the efficacy of different initial doses or glucocorticoid tapering. The aim of this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cimmino, Marco A, Parodi, Massimiliano, Montecucco, Carlomaurizio, Caporali, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114801/
https://www.ncbi.nlm.nih.gov/pubmed/21569559
http://dx.doi.org/10.1186/1471-2474-12-94

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114801/
https://www.ncbi.nlm.nih.gov/pubmed/21569559
http://dx.doi.org/10.1186/1471-2474-12-94

Ejemplares similares